ReviewJournal of family medicine and primary care2022
Analysis of the prescribing pattern of antidepressants and the side effects in depression patients.
Review in Journal of family medicine and primary care, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
7 citing papers in PubMed.
- Antidepressant prescribing patterns and patient-reported adverse effects: a cross-sectional study from Pakistan.Annals of general psychiatry · 2026Article
- Assessment of Anti-depressant-Induced Self-Reported Adverse Drug Reactions Among Patients in a Tertiary Care Hospital in Nepal: A Cross-Sectional Study.Drugs - real world outcomes · 2026Article
- 11,12-Diacetyl-Carnosol Ameliorates Depression-Like Behaviors and Memory Dysfunction in CUMS Mouse Model via Inhibiting HMGB1-Mediated Neuroinflammation.CNS neuroscience & therapeutics · 2025Article
- Reliability and validity of the Chinese Version of the Frequency, Intensity, and Burden of Side Effects Rating.Frontiers in psychiatry · 2025Article
- Global research trends in the intestinal microflora and depression: bibliometrics and visual analysis.Frontiers in cellular and infection microbiology · 2025Review
- Neuroinflammation and stress-induced pathophysiology in major depressive disorder: mechanisms and therapeutic implications.Frontiers in cellular neuroscience · 2025Review
- Prescription of benzodiazepines and antidepressants among Sami and non-Sami - How childhood violence shapes prescription patterns: the SAMINOR 2 questionnaire survey and the Norwegian prescription database.BMC public health · 2024Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
1 author.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Major depressive disorder (MDD) is a mental disorder characterized by impairment in mood regulation, loss of interest or pleasure, feelings of guilt, low self-worth, disturbed sleep and appetite, feelings of tiredness, and poor concentration. It is estimated to be the third leading cause of disability and about 350 million people suffer from depression worldwide. Treatment selection include consideration of the patient's personal history of medication response, side effects, drug preference, coexisting psychiatric disorders, accessibility, cultural, social, and situational factors. The main objectives in this study are to analyze prescription pattern of antidepressants, to assess treatment outcomes and partial remission in depression, and to evaluate the side effects in patients receiving antidepressant medications. The investigators will obtain the patient demographic data, disease information, medical issues, and other relevant patient information by interviewing them and referring patient medical records in the hospital (both inpatients and outpatients) documented in a self-designed case report form along with assessment of Hamilton Depression Rating Scale (HMDR), Patient Health Questionnaire (PHQ-9), and Morisky Green Levine Medication Adherence questionnaire (MGLMAQ). Adherence to medications was assessed using Morisky Green Levine Scale in 70 previously diagnosed subjects. Most of the subjects (32.85%) were found to have low adherence to medications, whereas 20.00% were highly adherent. There was a high rate of antidepressant discontinuation without consultation with physician. A closer communication between patients and physicians should be encouraged to enhance persistence to medications and improve outcomes. Recognition of depression as a significant risk factor for noncompliance with medical treatment carries the potential to improve medical practice, reduce patient disability, enhance patient functioning, and improve healthcare outcomes.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.